Overview

Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy and safety of lumiracoxib in patients with primary knee osteoarthritis (OA).
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Celecoxib
Diclofenac
Lumiracoxib